Live Breaking News & Updates on Novocure Limited Daily
Stay updated with breaking news from Novocure limited daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NovoCure (NASDAQ: NVCR) has recently received a number of price target changes and ratings updates: 4/3/2024 – NovoCure had its price target lowered by analysts at Wells Fargo & Company from $49.00 to $42.00. They now have an “overweight” rating on the stock. 3/27/2024 – NovoCure had its “neutral” rating reaffirmed by analysts at Wedbush. […] ....
A number of firms have modified their ratings and price targets on shares of NovoCure (NASDAQ: NVCR) recently: 8/17/2023 – NovoCure is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 8/8/2023 – NovoCure was upgraded by analysts at Piper Sandler from a “neutral” rating to an “overweight” rating. They […] ....